← All organizations

Abgenix

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 1, 2003

Acquired by Amgen on Jan 1, 2005

Timeline

1990s

Jan 1, 1996
Abgenix— Founded

2000s

Jan 1, 2000
Immgenics— Acquired
Jan 1, 2000
IntraImmune Therapies— Acquired
Jan 1, 2005
Amgen— Acquired By

Drugs by trial phase (3 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

gavilimomab

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (3)

NCT00061126Lead sponsorPhase 2Apr 1, 2003
NCT00035828Lead sponsorPhase 2Dec 1, 2001
NCT00035880Lead sponsorPhase 2/Phase 3Oct 1, 1999

Details

Founded: Fremont, CA, US Jan 1, 1996
Last known activity: Apr 1, 2003